 | • レポートコード：MRC2303J0036 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、220ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートによると、2021年に5,837.36百万ドルであった世界のプレフィルドシリンジ市場規模は、2022年に6,286.74百万ドルになり、2027年までにCAGR 7.87％で拡大して9,199.27百万ドルに達するとみられています。本書は、プレフィルドシリンジの世界市場を対象とした調査結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、デザイン別（カスタマイズ型、デュアルチャンバー型、シングルチャンバー型）分析、製品タイプ別（ガラス製、プラスチック製）分析、治療カテゴリー別（関節炎、ヘパリン、インスリン、PCSK9阻害剤、ワクチン）分析、用途別（アナフィラキシー、癌、糖尿病、眼科、関節リウマチ）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など、下記の項目を掲載しています。なお、本書内の企業情報としては、Becton, Dickinson and Company、Catalent, Inc.、Dätwyler Holding Inc.、Elcam Medical、Fresenius Kabi、Gerresheimer AG、MedPro Group、MedXL Inc.、Micsafe、Micsafe Medical Group、Nipro Corporation、Novartis AGなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のプレフィルドシリンジ市場規模：デザイン別 - カスタマイズ型プレフィルドシリンジの市場規模 - デュアルチャンバー型プレフィルドシリンジの市場規模 - シングルチャンバー型プレフィルドシリンジの市場規模 ・世界のプレフィルドシリンジ市場規模：製品タイプ別 - ガラス製プレフィルドシリンジの市場規模 - プラスチック製プレフィルドシリンジの市場規模 ・世界のプレフィルドシリンジ市場規模：治療カテゴリー別 - 関節炎プレフィルドシリンジの市場規模 - ヘパリンプレフィルドシリンジの市場規模 - インスリンプレフィルドシリンジの市場規模 - PCSK9阻害剤プレフィルドシリンジの市場規模 - ワクチンプレフィルドシリンジの市場規模 ・世界のプレフィルドシリンジ市場規模：用途別 - アナフィラキシーにおける市場規模 - 癌における市場規模 - 糖尿病における市場規模 - 眼科における市場規模 - 関節リウマチにおける市場規模 ・世界のプレフィルドシリンジ市場規模：地域別 - 南北アメリカのプレフィルドシリンジ市場規模 アメリカのプレフィルドシリンジ市場規模 カナダのプレフィルドシリンジ市場規模 ブラジルのプレフィルドシリンジ市場規模 ... - アジア太平洋のプレフィルドシリンジ市場規模 日本のプレフィルドシリンジ市場規模 中国のプレフィルドシリンジ市場規模 インドのプレフィルドシリンジ市場規模 韓国のプレフィルドシリンジ市場規模 台湾のプレフィルドシリンジ市場規模 ... - ヨーロッパ/中東/アフリカのプレフィルドシリンジ市場規模 イギリスのプレフィルドシリンジ市場規模 ドイツのプレフィルドシリンジ市場規模 フランスのプレフィルドシリンジ市場規模 ロシアのプレフィルドシリンジ市場規模 ... - その他地域のプレフィルドシリンジ市場規模 ・競争状況 ・企業情報 |
The Global Prefilled Syringes Market size was estimated at USD 5,837.36 million in 2021 and expected to reach USD 6,286.74 million in 2022, and is projected to grow at a CAGR 7.87% to reach USD 9,199.27 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Prefilled Syringes to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Design, the market was studied across Customized Prefilled Syringes, Dual-Chamber Prefilled Syringes, and Single-Chamber Prefilled Syringes.
Based on Product Type, the market was studied across Glass Pre Filled Syringes and Plastic Pre Filled Syringes.
Based on Therapeutic Category, the market was studied across Arthritis Pre Filled Syringes, Heparin Pre Filled Syringes, Insulin Pre Filled Syringes, PCSK9 Inhibitor Pre Filled Syringes, and Vaccine Pre Filled Syringes.
Based on Application, the market was studied across Anaphylaxis, Cancer, Diabetes, Ophthalmology, Rheumatoid Arthritis, and Thrombosis.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Prefilled Syringes market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Prefilled Syringes Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Prefilled Syringes Market, including Becton, Dickinson and Company, Catalent, Inc., Dätwyler Holding Inc., Elcam Medical, Fresenius Kabi, Gerresheimer AG, MedPro Group, MedXL Inc., Micsafe, Micsafe Medical Group, Nipro Corporation, Novartis AG, Owen Mumford Ltd, Schott AG, SHL Medical AG, SMC Ltd, Stevanato Group, SYGNIS AG, Terumo Corporation, Unilife Corporation, Vetter Pharma International GmbH, Weigao Group, West Pharmaceutical Services, Inc., and Ypsomed Holding.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Prefilled Syringes Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Prefilled Syringes Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Prefilled Syringes Market?
4. What is the competitive strategic window for opportunities in the Global Prefilled Syringes Market?
5. What are the technology trends and regulatory frameworks in the Global Prefilled Syringes Market?
6. What is the market share of the leading vendors in the Global Prefilled Syringes Market?
7. What modes and strategic moves are considered suitable for entering the Global Prefilled Syringes Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing adoption of self-care devices and digitalization
5.1.1.2. Rapid growth in generic products
5.1.2. Restraints
5.1.2.1. Dearth of prefilled syringes with integrated safety features
5.1.3. Opportunities
5.1.3.1. Growing healthcare infrastructure across emerging countries
5.1.3.2. Increasing adoption of wearable drug delivery technologies
5.1.4. Challenges
5.1.4.1. Availability of cost effective alternatives
5.2. Cumulative Impact of COVID-19
6. Prefilled Syringes Market, by Design
6.1. Introduction
6.2. Customized Prefilled Syringes
6.3. Dual-Chamber Prefilled Syringes
6.4. Single-Chamber Prefilled Syringes
7. Prefilled Syringes Market, by Product Type
7.1. Introduction
7.2. Glass Pre Filled Syringes
7.3. Plastic Pre Filled Syringes
8. Prefilled Syringes Market, by Therapeutic Category
8.1. Introduction
8.2. Arthritis Pre Filled Syringes
8.3. Heparin Pre Filled Syringes
8.4. Insulin Pre Filled Syringes
8.5. PCSK9 Inhibitor Pre Filled Syringes
8.6. Vaccine Pre Filled Syringes
9. Prefilled Syringes Market, by Application
9.1. Introduction
9.2. Anaphylaxis
9.3. Cancer
9.4. Diabetes
9.5. Ophthalmology
9.6. Rheumatoid Arthritis
9.7. Thrombosis
10. Americas Prefilled Syringes Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Prefilled Syringes Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Prefilled Syringes Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Becton, Dickinson and Company
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Catalent, Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Dätwyler Holding Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Elcam Medical
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Fresenius Kabi
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Gerresheimer AG
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. MedPro Group
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. MedXL Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Micsafe
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Micsafe Medical Group
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Nipro Corporation
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Novartis AG
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Owen Mumford Ltd
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Schott AG
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. SHL Medical AG
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. SMC Ltd
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Stevanato Group
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. SYGNIS AG
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Terumo Corporation
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Unilife Corporation
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Vetter Pharma International GmbH
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Weigao Group
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. West Pharmaceutical Services, Inc.
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. Ypsomed Holding
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing